Unlock Investment Opportunities in Advanced Therapies
The Investment Summit is your front-row seat to the future of biotech funding. Held on 07 September 2026, this focused morning programme will bring together Europe’s most forward-thinking investors, biotech pioneers, and strategic partners for insight-rich discussion and high-value connections. Whether you're investing in innovation or seeking it, this is where the deals begin.
A Strategic Opportunity for Biotechs, Investors — and Sponsors
The Summit is designed for action. Investors gain access to a curated cohort of startups, founders receive expert guidance and exposure, and sponsors position their brand at the epicentre of innovation. With 2025’s agenda tailored to the evolving European market, this is the most focused CGT investment platform in the region.
Whether you’re funding the future or building it, the Summit is your gateway to pre-qualified opportunities and strategic visibility.
View the 2026 Agenda
What to Expect on the day
Cell and Genes most exclusive Investment Summit goes beyond panels and pitches. It’s built to spark real opportunities — through live discussions, startup showcases, and strategic networking. Backed by global leaders and investors, it sets the tone for what’s to come across the main event.
Start with macro and micro trends shaping CGT investment — from capital flows to platform-based valuations.
Biotech CEOs share real-world experiences in securing funding, navigating milestones, and scaling in complex markets.
Want a preview of the ATE community?
See who was in the room this year and the organisations leading the way in advanced therapies.
Download the 2025 Attendee List
)
)
)
)
)
)
)
)
)
)
)